title: Vaccinia virus tropism for primary hematolymphoid cells is determined by restricted expression of a unique virus receptor.
abstract: The presumed broad tropism of poxviruses has stymied attempts to identify both the cellular receptor(s) and the viral determinant(s) for binding. Detailed studies of poxvirus binding to and infection of primary human cells have not been conducted. In particular, the determinants of target cell infection and the consequences of infection for cells involved in the generation of antiviral immune responses are incompletely understood. In this report, we show that vaccinia virus (VV) exhibits a more restricted tropism for primary hematolymphoid human cells than has been previously recognized. We demonstrate that vaccinia virus preferentially infects antigen-presenting cells (dendritic cells, monocytes/macrophages, and B cells) and activated T cells, but not resting T cells. The infection of activated T cells is permissive, with active viral replication and production of infectious progeny. Susceptibility to infection is determined by restricted expression of a cellular receptor that is induced de novo upon T-cell activation and can be removed from the cell surface by either trypsin or pronase treatment. The VV receptor expressed on activated T cells displays unique characteristics that distinguish it from the receptor used to infect cell lines in culture. The observed restricted tropism of VV may have significant consequences for the understanding of natural poxvirus infection and immunity and for poxvirus-based vaccine development.
authors.affiliation: Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia 30329, USA.
authors.forename: Ann
authors.initials: A
authors.lastname: Chahroudi
authors.forename: Rahul
authors.initials: R
authors.lastname: Chavan
authors.forename: Natalia
authors.initials: N
authors.lastname: Kozyr
authors.forename: Natalia
authors.initials: N
authors.lastname: Koyzr
authors.forename: Edmund K
authors.initials: EK
authors.lastname: Waller
authors.forename: Guido
authors.initials: G
authors.lastname: Silvestri
authors.forename: Mark B
authors.initials: MB
authors.lastname: Feinberg
mesh_terms: D000818:Animals; D005260:Female; D015870:Gene Expression; D008213:Lymphocyte Activation; D051379:Mice; D008807:Mice, Inbred BALB C; D011402:Pronase / Q000494:pharmacology; D011991:Receptors, Virus / Q000502:physiology*; D013601:T-Lymphocytes / Q000821:virology*; D018523:Tropism; D014357:Trypsin / Q000494:pharmacology; D014616:Vaccinia virus / Q000235:genetics / Q000502:physiology*
chemical_list: D011991:Receptors, Virus; D014357:Trypsin; D011402:Pronase